A premature, malnourished infant had seizures and abnormal neurological function associated with topical gamma benzene hexachloride (lindane) therapy. The level of gamma benzene hexachloride in his blood was 17 times greater than expected after a single topical application of 1% gamma benzene hexachloride. Significant levels developed in another child's blood after repeated applications of small amounts to areas of dermatitis and excoriations on the skin. The use of topical gamma benzene hexachloride in pediatric patients is reviewed because of increased evidence of unpredictable absorption and toxicity.
(Arch Dermatol 115:1224-1225, 1979)
Pramanik AK, Hansen RC. Transcutaneous Gamma Benzene Hexachloride Absorption and Toxicity in Infants and Children. Arch Dermatol. 1979;115(10):1224–1225. doi:10.1001/archderm.1979.04010100044018
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: